Follow
Parameswaran Nair
Parameswaran Nair
Professor of Medicine, McMaster University
Verified email at mcmaster.ca - Homepage
Title
Cited by
Cited by
Year
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia
P Nair, MMM Pizzichini, M Kjarsgaard, MD Inman, A Efthimiadis, ...
New England Journal of Medicine 360 (10), 985-993, 2009
16112009
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised …
JM FitzGerald, ER Bleecker, P Nair, S Korn, K Ohta, M Lommatzsch, ...
The Lancet 388 (10056), 2128-2141, 2016
13232016
Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma
KF Rabe, P Nair, G Brusselle, JF Maspero, M Castro, L Sher, H Zhu, ...
New England journal of medicine 378 (26), 2475-2485, 2018
10272018
Oral glucocorticoid–sparing effect of benralizumab in severe asthma
P Nair, S Wenzel, KF Rabe, A Bourdin, NL Lugogo, P Kuna, P Barker, ...
New England journal of medicine 376 (25), 2448-2458, 2017
9552017
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study
M Castro, S Mathur, F Hargreave, LP Boulet, F Xie, J Young, HJ Wilkins, ...
American journal of respiratory and critical care medicine 184 (10), 1125-1132, 2011
8722011
Omalizumab for asthma in adults and children
R Normansell, S Walker, SJ Milan, EH Walters, P Nair
Cochrane database of systematic reviews, 2014
7902014
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
L Jayaram, MM Pizzichini, RJ Cook, LP Boulet, C Lemiere, E Pizzichini, ...
European Respiratory Journal 27 (3), 483-494, 2006
7482006
Altered respiratory physiology in obesity
K Parameswaran, DC Todd, M Soth
Canadian respiratory journal 13, 203-210, 2006
6902006
Induced sputum cell counts in healthy adults
J Belda, R Leigh, K Parameswaran, PM O'BYRNE, MR Sears, ...
American journal of respiratory and critical care medicine 161 (2), 475-478, 2000
5342000
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
E Pizzichini, MMM Pizzichini, P Gibson, K Parameswaran, GJ Gleich, ...
American journal of respiratory and critical care medicine 158 (5), 1511-1517, 1998
5161998
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
SG Smith, R Chen, M Kjarsgaard, C Huang, JP Oliveria, PM O'Byrne, ...
Journal of Allergy and Clinical Immunology 137 (1), 75-86. e8, 2016
4922016
Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications
D Robinson, M Humbert, R Buhl, AA Cruz, H Inoue, S Korom, NA Hanania, ...
Clinical & Experimental Allergy 47 (2), 161-175, 2017
4192017
Role of biologics in asthma
MC McGregor, JG Krings, P Nair, M Castro
American journal of respiratory and critical care medicine 199 (4), 433-445, 2019
3972019
Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis
AM Wilson, PM O'Byrne, K Parameswaran
The American journal of medicine 116 (5), 338-344, 2004
3712004
Safety and efficacy of a CXCR 2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial
P Nair, M Gaga, E Zervas, K Alagha, FE Hargreave, PM O'byrne, ...
Clinical & Experimental Allergy 42 (7), 1097-1103, 2012
3592012
Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma
P Nair, SJ Milan, BH Rowe
Cochrane Database of Systematic Reviews, 2012
3272012
Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma
P Nair, SJ Milan, BH Rowe
Cochrane Database of Systematic Reviews, 2012
3212012
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the …
I Agache, J Beltran, C Akdis, M Akdis, C Canelo‐Aybar, GW Canonica, ...
Allergy 75 (5), 1023-1042, 2020
3042020
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The lancet respiratory medicine 7 (1), 46-59, 2019
2792019
The trials and tribulations of IL-5, eosinophils, and allergic asthma
PM O'Byrne, MD Inman, K Parameswaran
Journal of allergy and clinical immunology 108 (4), 503-508, 2001
2522001
The system can't perform the operation now. Try again later.
Articles 1–20